The International conference on prehypertension and cardio metabolic syndrome
Hilton Vienna
Am Stadtpark 1030 Vienna
Am Stadtpark, Austria
We warmly invite you to take part in this unique international conference which will  deal with Hypertension, Diabetes, Dyslipidemia, Obesity and Cardio Metabolic Syndrome. It will be of interest to fields in medicine, such as: Nephrology, Endocrinology, Internal Medicine, Primary Care, Cardiology, Imaging – Innovative & Routine Methods.
Prehypertension - Defined by  ESH/ISH guidelines as borderline blood pressure values as high normal values, while the JNC VII  defined a BP category of “Prehypertension� for systolic and diastolic BP: 120 to 139 mm Hg and 85 to 89 mm Hg, respectively.

Who Should Attend

The conference will deal with the subjects of: Hypertension, Diabetes, Dyslipidemia, Obesity
 and Cardio Metabolic Syndrome. It will be of interest to fields in medicine, such as:

*  Nephrology
*  Endocrinology
*  Internal Medicine
*  Primary Care
*  Cardiology
*  Imaging – Innovative & Routine Methods

Schedule of Presentations:

Thursday, February 24, 2011
14:00:00 Registration
17:00:00 Opening Ceremony
20:00:00 Get Together
Friday, February 25, 2011
08:00:00 Registration
08:25:00 Opening Plenary Session Reuven Zimlichman, Bruno Watschinger
08:30:00 Greetings Reuven Zimlichman, Bruno Watschinger
08:40:00 Prehypertension | History Definition and Epidemiology Stevo Julius
09:10:00 Pathophysiological and Clinical Consequences of Prehypertension Daniel A. Duprez
09:30:00 Is it Justified to Merge Normal and High Normal Blood Pressure Into Prehypertension? Robert Fagard
09:50:00 Debate | Prehypertension Is it a Disease or Disease Invention? Pro / Con Stevo Julius
10:10:00 Panel Discussion Daniel A. Duprez, Robert Fagard, Stevo Julius, Reuven Zimlichman
10:30:00 Coffee Break
11:00:00 Plenary Session | Prehypertension and The Cardio Metabolic Syndrome Basil S. Lewis, Daniel A. Duprez
11:05:00 Future use of Personalized Medicine in Development of Primary Prevention of Cardio Metabolic Syndrome Pavel Hamet
11:10:00 Prehypertension and The Cardio Metabolic Syndrome | Cont.
11:20:00 Prehypertension and Cardio Metabolic Syndrome Data in Europe Cetin Erol
11:40:00 Subclinical Coronary Atherosclerosis Defined as Coronary Artery Calcification is Associated with Prehypertension and Outcome Results of the Heinz Nixdorf Recall Study Raimund Erbel
12:00:00 Translational pre-clinical analysis of Non-Alcoholic Fatty Liver Disease for the Metabolic Syndrome by non-invasive in-vivo Magnetic Resonance Spectroscopy Oliver Steinbach
12:20:00 Pre-hypertension | Clinical Characteristics and Long-Term Outcome in the Real World Giuseppe Ambrosio
12:40:00 Metabolic and Vascular Effects of Exercise in Metabolicly Compromised Patients Thomas Wascher
13:00:00 Lunch
14:00:00 Free Communications | Prehypertension and the Cardio Metabolic Syndrome
14:10:00 Plasma Adiponectin, but not Asymmetric Dimethylarginine (ADMA) Level is Associated with Insulin Resistance in Normotensive Offspring of Subjects with Essential Hypertension
14:20:00 In Germany Fifty Percent Of Male Primary Care Patients Aged 18 to 99 Years Presented With Elevated Blood Pressures In The Prehypertensive State | The German Metabolic and Cardiovascular Risk Study (GEMCAS)
14:30:00 Clinical Significance of Diagnosis of Prehypertensive Patients with Primary Aldosteronism
14:40:00 Arterial Stiffness in Subjects with Different Components of Metabolic Syndrome
14:50:00 Free Communications: Prehypertension and the Cardio Metabolic Syndrome | Cont.
15:00:00 Increased Platelet Activation In Young Patients With Prehypertension
15:10:00 Garlic, Chocolate or Tomatoes for Prehypertension?
15:15:00 Blood Pressure Load, Proteinuria and Renal Function in Pre- Hypertensive Children
15:20:00 Plasmatic Insulin Regulated Aminopeptidase Activity in Type 2 Diabetes Mellitus
15:30:00 Coffee Break
16:00:00 Plenary Session | Pathophysiology of Prehypertension Charalambos Vlachopoulos, Bruno Watschinger
16:05:00 Vascular Aspects (Macrovascular and Microvascular) Charalambos Vlachopoulos
16:20:00 Relationship Between Arterial Function and the Heart Thomas Weber
16:40:00 The Kidney (Early Markers, Progress to Disease) Peter W. de Leeuw
17:00:00 Chronic Kidney Disease and Prehypertension Luis M. Ruilope
17:20:00 Microalbuminuria, as a Feature of "Pre"-Organ Damage Bruno Watschinger
17:40:00 Systolic, Diastolic and Pulse Pressure Monitoring Petr Kala
Saturday, February 26, 2011
08:00:00 Registration
08:25:00 Satellite symposium | Arterial Properties in Prehypertension John R. Cockcroft
08:30:00 Premature Vascular Ageing John R. Cockcroft
09:00:00 Assessment of Arterial Stiffness in Clinical Practice Ian B. Wilkinson
09:30:00 Pre-Hypertension and Cardiovascular Haemodynamics in Young Individuals | The ENIGMA Study Carmel McEniery
10:00:00 Panel Discussion John R. Cockcroft, Carmel McEniery, Ian B. Wilkinson, Charalambos Vlachopoulos
10:30:00 Coffee Break
11:00:00 Arterial Plasma Catecholamines Predict Increased Blood Pressure, Weight Gain and Glucose Intolerance after 18 years in Borderline Hypertensive Young Men Sverre E. Kjeldsen
11:00:00 Plenary Session | Cardiovascular Consequences of Prehypertension Sverre E. Kjeldsen, Peter W. de Leeuw
11:20:00 Cardiac and Vascular Damage in Prehypertnsion Enrico Agabiti Rosei
11:40:00 Prehypertension and (Pre)-Chronic Kidney Disease (CKD) – Fact or Fiction? Alexander Rosenkranz
12:00:00 Primary Aldosteronism in Prehypertensive and Stage I Hypertensive Patients Gian Paolo Rossi
12:20:00 Panel Discussion | Evaluation and Approach of the Prehypertensive Patients Gian Paolo Rossi, Sverre E. Kjeldsen, Alexander Rosenkranz
13:00:00 Lunch
13:55:00 Plenary Session | Clinical Trials in Prehypertension Daniel A. Duprez, Csaba Farsang
14:00:00 Lessons From the TROPHY Trial Stevo Julius
14:20:00 Lessons From Additional Trials (CHINOM, PHARAO and STRONG HEART)
14:40:00 Is Regression From Hypertension to Prehypertension Feasible? The Rationale and Design of The STAR CAST Study Hiroyuki Sasamura
15:00:00 Panel Discussion: Recommendations for Future Trials – What is Needed? Csaba Farsang, Stevo Julius, Daniel A. Duprez, Hiroyuki Sasamura
15:15:00 Coffee Break
15:40:00 Free Communications | The Arteries and Prehypertension
15:45:00 Associations of Plasma Homocysteine Levels with Arterial Stiffness in Prehypertensive Individuals
16:00:00 Segmental Aortic Stiffness Measured by MRI and its Effect on Cardiovascular Risk Assessment in Patients with Abdominal Aortic Aneurysm (AAA)
16:10:00 Relationship Between Arterial Stiffness and Increase of Blood Pressure During Exercise in Normotensive Persons
16:15:00 Free Communications | The Arteries and Prehypertension – Cont
16:20:00 Orlistat-Induced Weight Loss Improves Resistance Vessel Smooth Muscle but not Endothelium-Dependent Function in Obese Hypertensive Human Subjects William G. Haynes
16:30:00 Prehypertension and Carotid Intima-media Thickness in a Healthy population - Results of the Heinz Nixdorf Recall Study
16:40:00 A Novel Marker of Hypertensive Vascular Lesions : D-ROMs Test and BAP Test as A Marker of Oxidative Stress
16:50:00 Early Autonomic Cardiovascular Dysregulation in Young Healthy Adults with Positive Family History for Increased Cardiovascular Risk
17:00:00 Plenary Session | Non Pharmacologic Approach to Prehypertension Talma Rosenthal
17:05:00 Lifestyle Change in Prehypertension (Changing Way of Life) Talma Rosenthal
17:20:00 Overview on Smoking and Prehypertension Rudolf de Chatel
17:40:00 Tomato Lycopene and Other Phytonutriens for the Prevention of Metabolic Syndrome Ester Paran
18:00:00 Panel Discussion | The Role and Place of Non Pharmacological Approach in Prehypertension Talma Rosenthal, Ester Paran , Jiri Widimsky Jr
Sunday, February 27, 2011
08:00:00 Registration
08:30:00 Plenary session | Pharmacological Therapy of Prehypertension Thomas Unger
08:35:00 Prehypertension and hypertension | a case for OTC-drugs Thomas Unger
08:50:00 Shall We Give Antihypertensive Drugs to a Patient with High Normal Blood Pressure? Csaba Farsang
09:10:00 Adverse Metabolic Consequences of Antihypertensive Drug Treatment Guntram Schernthaner
09:30:00 Panel Discussion
10:15:00 Coffee Break
10:45:00 Closure Plenary Session | Conclusions and Future Perspectives and Recommendations Daniel A. Duprez
10:45:00 Prehypertension - Is it a Disease and Should it be Treated?
11:15:00 The Therapeutic Approach - Non Pharmacological and Pharmacological – Recommendations Stevo Julius
11:45:00 Prehypertension Guidelines Chair, Panel Discussion and Audience Daniel A. Duprez, Basil S. Lewis, Reuven Zimlichman
12:15:00 Conference Closure
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.